BOTOX® vs. XEOMIN® for Chronic Migraine

Clinical trial NCT05598723 · RECRUITING

Trial details

NCT number: NCT05598723
Sponsor: Naval Medical Center Camp Lejeune
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Migraine

Start date: 2023-02-24
Primary completion: 2027-02-24
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.